Insiders · Profile

Derynck Mika K

Director at Enliven Therapeutics. Filing since 4 Aug 2026. CIK 0001865125

Company

Date

Role

Action

Shares

Amount

Of holding

ELVN Enliven Therapeutics, Inc.

4 Aug 2026

Director

Sold on a plan

158,795

$9.56M

100%

1 decision on file.